Valion Bio increases equity plan share authorization to 3.2M shares

Valion Bio's board and shareholders approved a second amendment to the 2021 Equity Incentive Plan, increasing authorized shares from 637,958 to 3,219,566 shares effective May 28, 2026. The plan includes annual automatic increases of up to 5% of outstanding shares through January 1, 2031, providing expanded capacity for employee compensation and equity awards.